Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 6 of 6 entries
Sorted by: Best Match Show Resources per page
Assessing change in core autism symptoms: challenges for pharmacological studies.

Journal of child and adolescent psychopharmacology

Aman MG, Arnold LE, Hollway JA.
PMID: 25978740
J Child Adolesc Psychopharmacol. 2015 May;25(4):282-5. doi: 10.1089/cap.2015.28999.mga.

No abstract available.

An Overview of Bioinformatics Methods for Analyzing Autism Spectrum Disorders.

Current pharmaceutical design

Nakashima S, Nacher JC, Song J, Akutsu T.
PMID: 31713477
Curr Pharm Des. 2020;25(43):4552-4559. doi: 10.2174/1381612825666191111154837.

Autism Spectrum Disorders (ASD) are a group of neurodevelopmental disorders and are well recognized to be biologically heterogeneous in which various factors are associated, including genetic, metabolic, and environmental ones. Despite its high prevalence, only a few drugs have...

Ethical Implications for Providers Regarding Cannabis Use in Children With Autism Spectrum Disorders.

Pediatrics

Duvall SW, Lindly O, Zuckerman K, Msall ME, Weddle M.
PMID: 30610100
Pediatrics. 2019 Feb;143(2). doi: 10.1542/peds.2018-0558. Epub 2019 Jan 04.

Children with autism spectrum disorder (ASD) are at risk for self-injurious behaviors that can be difficult to treat in the context of co-occurring low IQ and adaptive skills. Increased prevalence and decriminalization of cannabis in some states have led...

Current status of biological treatment options in Autism Spectrum Disorder.

Asian journal of psychiatry

Eapen V, Nicholls L, Spagnol V, Mathew NE.
PMID: 28704714
Asian J Psychiatr. 2017 Dec;30:1-10. doi: 10.1016/j.ajp.2017.07.025. Epub 2017 Jul 06.

Autism Spectrum Disorders (ASDs) are characterised by deficits in social communication and restricted and repetitive behaviours. With an onset in early childhood, ASDs are thought to be heterogeneous, both genetically and clinically. This has led to the notion that...

Current state of evidence of cannabis utilization for treatment of autism spectrum disorders.

BMC psychiatry

Agarwal R, Burke SL, Maddux M.
PMID: 31664964
BMC Psychiatry. 2019 Oct 29;19(1):328. doi: 10.1186/s12888-019-2259-4.

The core symptoms and co-morbidities associated with autism spectrum disorders (ASD) affect daily living and quality of life. Existing pharmacological interventions are only able to attenuate some related symptoms but are unable to address the underlying etiologies associated with...

Why Is It Important to Protect Children with Mental Disorders from Medical Cannabis?.

Journal of developmental and behavioral pediatrics : JDBP

Bou Khalil R.
PMID: 26535885
J Dev Behav Pediatr. 2015 Nov-Dec;36(9):766. doi: 10.1097/DBP.0000000000000217.

No abstract available.

Showing 1 to 6 of 6 entries